GO
Loading...

Bristol-Myers Executive Charged With Insider Trading

FBI agents arrested Robert Ramnarine, a Bristol-Myers Squibbexecutive, on Thursday. He has been criminally charged with insider trading the call options of companies shortly before they were acquired, court papers show.

CNBC.com

Ramnarine, an assistant director for capital markets in Bristol-Myers' office in Princeton, N.J., was arrested by agents at a suburban New Jersey home this morning.

A three-count criminal complaint was unsealed this morning. According the complaint, he made more than $311,000 in illegal profit.

The insider trading in question involved several stocks, including ZymoGenetics, Pharmasset and Amylin Pharmaceuticals.

Ramnarine will have his initial court appearance later this afternoon. It is unclear whether Ramnarine has hired a lawyer for his defense.

In his position at Bristol-Myers Squibb, he was responsible for conducting due diligence concerning the pension plans of the company's acquisition targets.

No immediate response from Bristol-Myers Squibb was available.

— By CNBC's Jim Forkin. Reuters contributed to this article.

Contact U.S. News

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    › Learn More

Don't Miss

U.S. Video

  • Fantex Holdings provides an opportunity to investors to invest in professional athletes. Jack Brewer, The Brewer Group CEO, provides the athlete's perspective, and Buck French, Fantex Holdings co-founder and CEO, says the company plans to sign athletes across the world of sports.

  • How to invest in NFL players, and the risks associated with the investment, with Buck French, Fantex Holdings co-founder and CEO.

  • A look at three properties for sale in Detroit where Zillow finds the median sale price at about $167,350, with Jenilynn Estereicher, Century 21 Town & Country